Danish-based insulin and enzymesproducer Novo Industri A/S &lt;NVO.CO> said in a statement thatits "B" shares would be listed on stock exchanges in Zurich,Basel and Geneva from May 4.    The aim is to create broader European interest in Novostock, currently listed in Copenhagen, London and New York,said the statement issued after yesterday's ordinary generalmeeting.    Novo said more than 50 pct of its B shares were owned byU.S. Investors. The new listings, the first by a Danish companyon the Swiss exchanges, will not involve issuing of new sharecapital. REUTER&#3;